Salva, K. F., Copponex, C., Whiting, J., Hansen, D., Freeman, C. L., Puglianini, O. A. C., Liu, H., Nishihori, T., Blue, B., Locke, F., Jain, M., Grajales-Cruz, A., Shain, K., Baz, R., Alsina, M. (2025). Suppressive dexamethasone (SupDex) to prevent delayed non-icans delayed neurotoxicity (DNT) post ciltacabtagene-autoleucel(cilta-cel) in patients with relapsed myeloma.suppressive dexamethasone (SupDex) to prevent delayed non-icans delayed neurotoxicity (DNT) post ciltacabtagene-autoleucel(cilta-cel) in patients with relapsed myeloma.. Blood. https://doi.org/10.1182/blood-2025-5856